Emil Ivanov

Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland.

Allergan Plc is a global pharmaceutical company that develops, manufactures, and markets branded pharmaceutical, device, biologic, surgical, and regenerative medicine products for patients worldwide. The private company is based in Madison, NJ, with operations in approximately 100 countries. The company has a broad portfolio of leading brands and products in various therapeutic categories, including central nervous system, eye care, medical aesthetics, dermatology, gastroenterology, women's health, urology, and anti-infective. Allergan is an industry leader in open science, a model of research and development that focuses on identifying and developing innovative ideas and innovation for better patient care.

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Galderma Pharma SA discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. It offers drugs, medical dermatology solutions, and therapeutic skin care products for treating hair, nail, and skin diseases. The company was founded in 1981 and is headquartered in Lausanne, Switzerland.

Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Part of Dolder Bigler AG, Dolder AG is a Swiss company that specializes in producing high-quality plastics and specialty chemicals. The company is based in Basel, Switzerland and works with other industry leaders such as Coim, Eastman, Evonik, and Huntsman to provide top-of-the-line products for their customers. The company's laripur® tpu and ™ copolyester products are used for injection molding and extrusion, and offer a soft touch effect and higher heat and chemical resistance than other materials.

Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany.

Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors.

Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ.

Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France.

Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark.

Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov.

Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany.

Founded in 1997, Proactiv Skin Health Ltd. is a part of Guthy-Renker Partners, Inc. that provides sales and support services. The company is based in London, UK.

Avava, Inc. provides a non-invasive, FDA-cleared laser treatment that prevents and treats skin aging for all skin types. The private company is based in Waltham, MA. The treatment can also safely address pigmentary disorders. Avava was founded by R. Rox Anderson, Dieter Manstein, Henry Hin Lee Chan. The CEO is Irina Erenburg.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.

The Jed Foundation exists to protect emotional health and prevent suicide for nation's teens and young adults. It develops expert resources and create partnerships. The firm educates and equip students, families and communities. The company was founded in 2000 and is headquartered in New York, NY.